Sep 06, 2023 8:15am EDT Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Aug 17, 2023 8:05am EDT Processa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatment Approach for Improved Cancer Care
Aug 10, 2023 4:15pm EDT Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual Conference
Aug 08, 2023 8:15am EDT Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer
May 22, 2023 8:05am EDT Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Drug Congress
May 18, 2023 8:00am EDT Processa Pharmaceuticals to Conduct Next Generation Chemotherapy-Capecitabine Phase 2 Trial Based on FDA Guidance and Project Optimus Oncology Initiative
Apr 28, 2023 8:15am EDT Processa Pharmaceuticals to Present PCS12852 Gastroparesis Results at the Digestive Disease Week 2023 Annual Meeting
Mar 30, 2023 4:01pm EDT Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results
Mar 23, 2023 8:30am EDT Processa Pharmaceuticals to Host Conference Call to Discuss 2022 Year End Results and Provide Drug Development Update on March 30, 2023 at 4:30 p.m. EST
